| Pharmaceutical Information |
| Drug Name |
Acetohydroxamic acid |
| Drug ID |
BADD_D00028 |
| Description |
Acetohydroxamic Acid, a synthetic drug derived from hydroxylamine and ethyl acetate, is similar in structure to urea. In the urine, it acts as an antagonist of the bacterial enzyme urease. Acetohydroxamic Acid has no direct antimicrobial action and does not acidify urine directly. It is used, in addition to antibiotics or medical procedures, to treat chronic urea-splitting urinary infections. |
| Indications and Usage |
Used, in addition to antibiotics or medical procedures, to treat chronic urea-splitting urinary infections. |
| Marketing Status |
approved |
| ATC Code |
G04BX03 |
| DrugBank ID |
DB00551
|
| KEGG ID |
D00220
|
| MeSH ID |
C006358
|
| PubChem ID |
1990
|
| TTD Drug ID |
D0R9BG
|
| NDC Product Code |
49632-170; 0178-0500; 73309-355 |
| UNII |
4RZ82L2GY5
|
| Synonyms |
acetohydroxamic acid | N-hydroxyacetamide | N-hydroxyacetamidine | Lithostat | Uronefrex |
|
| Chemical Information |
| Molecular Formula |
C2H5NO2 |
| CAS Registry Number |
546-88-3 |
| SMILES |
CC(=O)NO |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
